108 related articles for article (PubMed ID: 6736206)
1. Relationship between plasma aldosterone and angiotensin II before and after noradrenergic inhibition in normal subjects and patients with mild essential hypertension.
Beretta-Piccoli C; Weidmann P; Boehringer K; Link L; Bianchetti MG; Morton JJ
J Clin Endocrinol Metab; 1984 Aug; 59(2):316-20. PubMed ID: 6736206
[TBL] [Abstract][Full Text] [Related]
2. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
Yamamoto Y
Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
Williams GH; Dluhy RG; Moore TJ
Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
[TBL] [Abstract][Full Text] [Related]
4. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
Wisgerhof M; Brown RD
J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
[TBL] [Abstract][Full Text] [Related]
5. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
Anderson GH; Howland T; Domschek R; Streeten DH
J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
[TBL] [Abstract][Full Text] [Related]
7. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic activity and aldosterone regulation: no evidence for an alpha-1 adrenoceptor-mediated influence in normal subjects.
Bianchetti L; Ferrier C; Beretta-Piccoli C; Fraser R; Morton JJ; Ziegler WH
Clin Endocrinol (Oxf); 1986 Jul; 25(1):87-95. PubMed ID: 3024874
[TBL] [Abstract][Full Text] [Related]
9. Blunted aldosterone responsiveness to angiotensin II in normotensive subjects with familial predisposition to essential hypertension.
Beretta-Piccoli C; Pusterla C; Städler P; Weidmann P
J Hypertens; 1988 Jan; 6(1):57-61. PubMed ID: 3351294
[TBL] [Abstract][Full Text] [Related]
10. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
11. Yohimbine and aldosterone responsiveness to angiotensin II or corticotrophin in normal subjects.
Lucchini E; Kressebuch H; Beretta-Piccoli C
Clin Exp Hypertens A; 1989; 11(4):649-63. PubMed ID: 2551545
[TBL] [Abstract][Full Text] [Related]
12. The adrenal receptor for angiotensin II is altered in essential hypertension.
Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
[TBL] [Abstract][Full Text] [Related]
13. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.
Wisgerhof M; Brown RD
J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808
[TBL] [Abstract][Full Text] [Related]
14. Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertension.
Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Shaw S
J Hum Hypertens; 1988 Mar; 1(4):267-76. PubMed ID: 3065505
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.
Beretta-Piccoli C; Bianchetti MG; Weidmann P; Boehringer K; Link L; Morton JJ
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S306-12. PubMed ID: 6184559
[TBL] [Abstract][Full Text] [Related]
16. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension.
Marks AD; Marks DB; Kanefsky TM; Adlin VE; Channick BJ
J Clin Endocrinol Metab; 1979 Feb; 48(2):266-70. PubMed ID: 429480
[TBL] [Abstract][Full Text] [Related]
17. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
Carey RM; Vaughan ED; Peach MJ; Ayers CR
J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
[TBL] [Abstract][Full Text] [Related]
18. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
19. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure control in normotensive members of hypertensive families.
Bianchetti MG; Beretta-Piccoli C; Weidmann P; Ferrier C
Kidney Int; 1986 Apr; 29(4):882-8. PubMed ID: 3520094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
